Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide

Infection and Immunity

Volumn 64, Issue 4, 1996, Pages 1220-1226

  Paoletti, Lawrence C ^a,b   Ross, Robin A ^a   Johnson, Kenneth D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CARBOHYDRATE ANTIGEN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BINDING SITE; GROWTH RATE; GROWTH REGULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE;

EID: 0030007418     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.4.1220-1226.1996     Document Type: Article

References (49)

1. Baltimore, R. S., D. L. Kasper, C. J. Baker, and D. K. Goroff. 1977. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. J Immunol 118:673-678.
2. Bortolussi, R., P. Ferrieri, and P. G. Quie. 1983 Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization Infect. Immun. 39:1136-1141.
3. Brunschede, H., T. L. Dove, and H. Bremer. 1977. Establishment of exponential growth after a nutritional shift-up in Escherichia coli B/r: accumulation of deoxyribonucleic acid, ribonucleic acid, and protein. J. Bacteriol. 129:1020-1033.
4. Calandra, G. B., and R. M. Cole. 1980. Lysis and protoplast formation of group B streptococci by mutanolysin. Infect. Immun. 28:1033-1037.
5. Chesbro, W., T. E. Evans, and R. Eifert. 1979. Very slow growth of Eschenchia coli. J. Bacteriol. 139:625-638.
6. Craven, D. E., M. S. Peppler, C. E. Frasch, L. F. Mocca, P. P. McGrath, and G. Washington. 1980. Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells. J. Infect. Dis. 142:556-568.
7. Davis, B. D., R. Dulbecco, H. N. Eisen, and H. S. Ginsberg. 1980. Microbiology, p. 33-34. Harper and Row, Philadelphia
8. DeCueninck, B., G. D. Shockman, and R. M. Swenson. 1982. Group B type III streptococcal cell wall: composition and structural aspects revealed through endo-N-acetylmuramidase-catalyzed hydrolysis. Infect. Immun. 35:572-581.
9. Demain, A. L. 1972. Cellular and environmental factors affecting the synthesis and excretion of metabolites. J. Appl. Biotechnol. 22:345-362.
10. Doran, T. I., D. C. Straus, and S. J. Mattingly. 1981. Factors influencing release of type III antigens by group B streptococci. Infect. Immun. 31:615-623.
11. Durham, D. L., S. J. Mattingly, T. I. Doran, T. W. Milligan, and D. C. Straus. 1981. Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model. Infect. Immun. 34:448-454.
12. Edwards, M. S., D. L. Kasper, H. J. Jennings, C. J. Baker, and W. A. Nicholson. 1982. Capsular sialic acid prevents activation of the alternative complement pathway by type III. group B streptococci. J. Immunol. 128:1278-1283.
13. Edwards, M. S., W. A. Nicholson, C. J. Baker, and D. L. Kasper. 1980. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J. Exp Med. 151:1275-1287.
14. Edwards, M. S., M. R. Wessels, and C. J. Baker. 1993. Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci Infect. Immun 61:2866-2871.
15. Gray, B. M., and D. G. Pritchard. 1992. Phase variation in the pathogenesis of group B streptococcal infections, p. 452-454 In G Orefici (ed.), New perspectives on streptococci and streptococcal infections. Gustav Fischer, Stuttgart, Germany.
16. Håkansson, S., A. M. Bergholm, S. E. Holm, B. Wagner, and M. Wagner. 1988 Properties of high and low density subpopulations of group B streptococci: enhanced virulence of the low density variant. Microb Pathog. 5:345-355.
17. Hulse, M. L., S. Smith, E. Y. Chi, A. Pham, and C. E. Rubens. 1993. Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells Infect. Immun. 61:4835-4841.
18. Jennings, H. J., E. Katzenellenbogen, C. Lugowski, and D. L. Kasper. 1983. Structure of the native polysaccharide antigens of type Ia and type Ib group B Streptococcus. Biochemistry 22:1258-1263.
19. Jennings, H. J., C. Lugowski, and D. L. Kasper. 1981. Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide. Biochemistry 20:4511-4518.
20. Jennings, H. J., K. G. Rosell, and U. L. Kasper. 1980 Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus. Can. J. Biochem. 58:112-120
21. Jennings, H. J., K. G. Rosell, E. Katzenellenbogen, and D. L. Kasper. 1983. Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus. J. Biol. Chem. 258:1793-1798.
22. Kuypers, J. M., L. M. Heggen, and C. E. Rubens. 1989. Molecular analysis of a region of the group B Streptococcus chromosome involved in type III capsule expression. Infect. Immun. 57:3058-3065.
23. Leninger, A. L. 1982. Principles of biochemistry, p. 258-259 Worth Publishers, Inc , New York.
24. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275
25. Marques, M. B., D. L. Kasper, M. K. Pangburn, and M. R. Wessels. 1992. Prevention of C3 deposition is a virulence mechanism of type III group B Streptococcus capsular polysaccharide. Infect. Immun. 60:3986-3993.
26. Mengistu, Y., C. Edwards, and J. R. Saunders. 1994. Continuous culture studies on the synthesis of capsular polysaccharide by Klebsiella pneumoniae K1. J Appl Bacteriol. 76:424-430.
27. Mian, F. A., T. R. Jarman, and R. C. Righelato. 1978. Biosynthesis of exopolysaccharide by Pseudomonas aeruginosa. J. Bacteriol. 134:418-422.
28. Miyazaki, S., O. Leon, and C. Panos. 1988. Adherence of Streptococcus agalactiae to synchronously growing human cell monolayers without lipoteichoic acid involvement. Infect. Immun. 56:505-512.
29. Musser, J. M., S. J. Mattingly, R. Quentin, A. Goudeau, and R. K. Selander. 1989. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad. Sci. USA 86:4731-4735.
30. Nealon, T. J., and S. J. Mattingly. 1984. Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells. Infect. Immun. 43:523-530.
31. O'Toole, D. K. 1983. Weighing technique for determining bacterial dry mass based on rate of moisture uptake. Appl. Environ. Microbiol. 46:506-508.
32. Paoletti, L. C., D. L. Kasper, F. Michon, J. DiFabio, H. J. Jennings, T. D. Tosteson, and M. R. Wessels. 1992. Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. J. Clin. Invest. 89:203-209.
33. Rubens, C. E., L. M. Heggen, R. F. Haft, and M. R. Wessels. 1993. Identification of cpsD, a gene essential for type III capsule expression in group B streptococci. Mol. Microbiol. 8:843-855.
34. Rubens, C. E., S. Smith, M. Hulse, E. Y. Chi, and G. van Belle. 1992. Respiratory epithelial cell invasion by group B streptococci. Infect. Immun. 60:5157-5163.
35. Rubens, C. E., M. R. Wessels, L. M. Heggen, and D. L. Kasper. 1987. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence Proc. Natl. Acad. Sci. USA 84:7208-7212.
36. Schuchat, A., and J. D. Wenger. 1994. Epidemiology of group B streptococcal disease. Risk factors, prevention strategy, and vaccine development. Epidemiol. Rev. 16:374-402.
37. St. Geme, J. W., III, and S. Falkow. 1991. Loss of capsule expression by Haemophilus influenzae type b results in enhanced adherence to and invasion of human cells. Infect. Immun. 59:1325-1333.
38. Sutherland, I. W. 1982. Biosynthesis of microbial exopolysaccharides. Adv. Microb. Physiol. 23:79-150.
39. van de Rijn, I., and R. E. Kessler. 1980. Growth characteristics of group A streptococci in a new chemically defined medium. Infect. Immun. 27:444-448.
40. van Verseveld, H. W., P. Bakker, T. van der Woude, C. Terleth, and F. K. de Graaf. 1985. Production of fimbrial adhesins K99 and F41 by enterotoxigenic Escherichia coli as a function of growth-rate domain Infect. Immun. 49:159-163.
41. Vermeulen, C., A. Cross, W. R. Byrne, and W. Zollinger. 1988. Quantitative relationship between capsule content and killing of K1-encapsulated Escherichia coli. Infect. Immun. 56:2723-2730.
42. von Hunolstein, C., L. Nicolini, S. D'Ascenzi, C. Volpe, G. Alfarone, and G. Orefici. 1993. Sialic acid and biomass production by Streptococcus agalactiae under different growth conditions. Appl. Microbiol. Biotechnol. 38:458-462.
43. Wessels, M. R., J. L. DiFabio, V.-J. Benedí, D. L. Kasper, F. Michon, J.-R. Brisson, J. Jelínková, and H. J. Jennings. 1991. Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide. J. Biol. Chem. 266:6714-6719.
44. Wessels, M. R., L. C. Paoletti, D. L. Kasper, J. L. DiFabio, F. Michon, K. Holme, and H. J. Jennings. 1990 Immunogenicity in animals of a polysaccharide protein conjugate vaccine against type III group B Streptococcus. J Clin. Invest. 86:1428-1433.
45. Wessels, M. B., L. C. Paoletti, A. K. Rodewald, F. Michon, J. DiFabio, H. J. Jennings, and D. L. Kasper, 1993. Stimulation of protective antibodies against types Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine. Infect. Immun. 61:4760-4766.
46. Wessels, M. R., V. Pozsgay, D. L. Kasper, and H. J. Jennings. 1987. Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus A revised structure for the type III group B streptococcal polysaccharide antigen. J. Biol. Chem. 262:8262-8267.
47. Wessels, M. R., C. E. Rubens, V. J. Benedí, and D. L. Kasper. 1989. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc. Natl. Acad Sci. USA 86:8983-8987.
48. Wibawan, I. W. T., C. Lammer, and F. H. Pasaribu. 1992. Role of hydrophobic surface proteins in mediating adherence of group B streptococci to epithelial cells. J. Gen. Microbiol. 138:1237-1242.
49. Yeung, M. K., and S. J. Mattingly. 1984. Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci. Infect. Immun. 44:217-221.